BriaCell Therapeutics (STU:8BT) Price-to-Free-Cash-Flow : N/A (As of Apr. 28, 2024)

BriaCell Therapeutics Price-to-Free-Cash-Flow Chart

BriaCell Therapeutics Annual Data
	Trend	Jul14	Jul15	Jul16	Jul17	Jul18	Jul19	Jul20	Jul21	Jul22	Jul23
Price-to-Free-Cash-Flow		Get a 7-Day Free Trial					-	-	-	-	-

BriaCell Therapeutics Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BriaCell Therapeutics's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, BriaCell Therapeutics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BriaCell Therapeutics's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's Price-to-Free-Cash-Flow falls into.

BriaCell Therapeutics Price-to-Free-Cash-Flow Calculation

BriaCell Therapeutics's Price-to-Free-Cash-Flow ratio for today is calculated as

BriaCell Therapeutics's Share Price of today is €2.00.
BriaCell Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.79.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

BriaCell Therapeutics  (STU:8BT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

BriaCell Therapeutics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BriaCell Therapeutics (STU:8BT) Business Description